Enrolling By Condition
A tracked trials dataset for our medical research coverage: what it measures, where the figures come from and when they were last checked.
Novartis, BMS halt autoimmune CAR-T trials
Novartis paused CD19 CAR-T trials after three patient deaths, and Bristol Myers Squibb halted enrollment in a similar program due to inflammatory...
Heart Failure Drug Combo Effects Modeled
A pooled analysis of 38,753 patients from nine trials provides individualized estimates for how combinations of modern heart failure drugs affect...
AusperBio raises $120M for hepatitis B trial
AusperBio Therapeutics raised $120 million in a series C round led by RA Capital to advance its hepatitis B drug candidate AHB-137 into phase 3...
Focal Therapy
Focal therapy for prostate cancer has divided physicians, with some considering it a viable alternative to traditional treatments and others viewing...
Capricor’s Duchenne Drug Study Highlights the Challenges of Rare Disease Trials
The FDA's recent decision on Capricor’s deramiocel for Duchenne muscular dystrophy underscores the complexities of rare disease clinical trials...
Regeneron's Pasatru Receives FDA Approval for Rare Bone Disease
Regeneron Pharmaceuticals' Pasatru has earned FDA approval for treating fibrodysplasia ossificans progressiva, a rare condition causing abnormal bone...
Experts Question Huidagene's Disclosures Following Patient Death
A recent patient death has raised concerns about Huidagene's transparency in clinical trials.